Open Book Extracts and Biopharmaceutical Research Company will research the full range of cannabinoids.
The FDA’s interest in the treatment as a potential therapy for sleep apnoea is “extremely encouraging”.
The study provides evidence to support the effectiveness of medical cannabis as a treatment for anxiety and depression.
The Canadian company is establishing research company Tetra Bio-Pharma Australia Pty Ltd.
The Spanish pharmaceutical company has said the approval marks a significant milestone for the advancement of its pipeline of projects.
Many Canadians have continued to source cannabis from illegal sources despite legalisation, new research finds.
Promising results reported from studies testing the efficacy of its lead compound.
A public consultation has now been launched on the science innovation and research centre that will be established by Peel NRE.
The Hawthorne Social Justice Fund, part of The Scotts Miracle-Gro Foundation, will provide funding through a multi-year sponsorship of the John R. Lewis Social Justice Fellows programme.
The AQSE Growth Market listed company has now begun the first stage of its research programme.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
